AI-Driven Discovery of Novel Predictors of Parkinson’s Disease Progression by GNS Healthcare Appears in The Lancet Neurology

Discovery May Accelerate the Development of New Drugs & Better Match New Drugs to Individual Patients CAMBRIDGE, Mass.– Sept 26, 2017 – GNS Healthcare (GNS), a leading precision medicine company, announced today the discovery of genetic and molecular markers of faster motor progression of Parkinson’s Disease (PD) patients, the LINGO2 gene together with a second genetic […]